查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362881

藥物釋放型支架市場規模、佔有率和趨勢分析報告：按塗層類型、用途、地區和細分市場預測，2023-2030年

Drug Eluting Stent Market Size, Share & Trends Analysis Report By Coating Type (Polymer-based Coatings (Non-biodegradable, Biodegradable)), Polymer-free Coatings, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

藥物釋放型支架市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球藥物釋放型支架市場規模預計將達到136.5億美元，預測期內年複合成長率為8.4%。

高齡化以及心血管疾病（CVD）、複雜病變、糖尿病和肥胖等危險因子的日益患病將推動預測期內對藥物釋放型支架的需求。此外，支架設計的技術進步，例如改進的塗層和藥物傳輸機制，正在提高這些設備的安全性和有效性，使它們對患者和醫療保健專業人員更具吸引力。

全球心血管疾病患病的增加正在刺激市場需求。根據2022年世界衛生聯合會（WHF）報告，全球有超過5億人持續罹患心血管疾病，2021年CVD將導致約2,050萬人死亡，佔全球整體死亡人數的近三分之一。冠狀動脈疾病和周邊動脈疾病疾病變得越來越常見，對 DES 等有效治療方案的需求也迅速增加。這些具有藥物塗層表面的支架為患者提供了微創解決方案，並有效防止血管再阻塞，從而改善患者的治療效果。

藥物釋放型支架市場受到 COVID-19大流行的嚴重影響，該流行病擾亂了醫療設備供應鏈。由於所有主要製造商都專注於對抗 COVID-19，其他領域的收益受到了重大影響。冠狀動脈支架市場的所有知名競爭都宣布，2020 年其介入性心臟病學產品組合（包括冠狀動脈支架設備）的收益出現下降，這主要是由於 COVID-19 大流行的影響。

藥物釋放型支架市場報告亮點

  • 以塗料來看，聚合物基塗料領域在2022年佔據了82.9%的主導收益佔有率。這一市場佔有率可能是由於其在支架開發方面的廣泛用途、經過驗證的藥物傳輸有效性以及適應各種治療劑的多功能性，使其受到製造商和醫療相關人員的歡迎。此外，聚合物塗層技術的不斷進步進一步鞏固了我們的市場主導地位。
  • 藥物釋放型支架市場依用途分為冠狀動脈疾病及周邊動脈疾病，2022年前者佔銷售額的85.9%。這一成長是由全球冠狀動脈疾病的高患病推動的，導致對藥物釋放型支架等有效治療方案的大量需求。
  • 北美地區在 2022 年佔據最大的收益佔有率，達到 43.08%，預計將在整個預測期內主導市場。北美擁有發達且先進的醫療基礎設施，包括醫院。此外，該地區心血管疾病的患病不斷上升，推動了對藥物釋放型支架等有效治療方案的需求。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 心血管疾病患病增加
    • 支架設計的技術進步
    • 老年人口增加
  • 市場抑制因素分析
    • 高成本藥物釋放型支架
  • 2022 年普及與成長前景預測
  • 營商環境分析
    • SWOT 分析；要素因素（政治/法律、經濟/技術）
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 藥物釋放型支架市場：塗層類型細分分析

  • 藥物釋放型支架：2022 年和 2030 年市場佔有率分析
  • 聚合物基塗料
  • 無聚合物塗層

第5章 藥物釋放型支架市場：用途細分分析

  • 藥物釋放型支架：2022 年和 2030 年市場佔有率分析
  • 冠狀動脈疾病
  • 周邊動脈疾病

第6章 藥物釋放型支架市場：區域分析

  • 2022 年及 2030 年藥物釋放型支架市場佔有率（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介/名單
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • Biosensors International
    • Cook Medical
    • B. Braun
    • Biotronik
    • Lepu Medical Technology
Product Code: 978-1-68038-999-9

Drug Eluting Stent Market Growth & Trends:

The global drug eluting stent market size is expected to reach USD 13.65 billion by 2030, advancing at a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. An aging population and the increasing prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive the demand for drug eluting stents over the forecast period. Additionally, ongoing technological advancements in stent design, including improvements in coatings and drug delivery mechanisms, are enhancing the safety and efficacy of these devices, making them more appealing to patients and healthcare professionals.

The increasing prevalence of cardiovascular diseases globally has fueled market demand. According to the World Health Federation report in 2022, over half a billion people globally continue to be affected by cardiovascular diseases, with CVD contributing to approximately 20.5 million deaths in 2021, accounting for nearly a third of all deaths globally. Conditions like coronary artery disease and peripheral artery disease are becoming increasingly common, leading to a surge in demand for effective treatment options such as DES. These stents, equipped with drug-coated surfaces, offer patients a minimally invasive solution, effectively preventing restenosis and leading to improved patient outcomes.

The market for drug eluting stents was significantly impacted by the COVID-19 pandemic, with disruptions in the supply chain of medical devices. Since the focus of all major manufacturers was to fight the COVID-19 battle, the revenues of other segments were highly impacted. All notable competitors in the market for coronary stents announced a decline in revenue for their interventional cardiology portfolios, which include coronary stent devices in 2020, owing mostly to the impact of the COVID-19 pandemic.

Drug Eluting Stent Market Report Highlights:

  • Based on coating, the polymer-based coating segment held the dominant revenue share of 82.9% in 2022. This share can be attributed to its extensive usage in stent development, proven efficacy in drug delivery, and versatility in accommodating various therapeutic agents, making it a preferred choice for manufacturers and healthcare professionals alike. Additionally, continuous advancements in polymer-based coating technology have further solidified its leading position in the market
  • Based on application, the market for drug eluting stents has been categorized into coronary artery disease and peripheral artery disease, with the former accounting for 85.9% of the revenue share in 2022. The growth can be attributed to the high prevalence of coronary artery disease globally, leading to a substantial demand for effective treatment options such as drug eluting stents
  • The North American region held the largest revenue share of 43.08% in 2022 and is expected to dominate the market through the forecast period. North America has a well-developed and advanced healthcare infrastructure, including hospitals. Additionally, the increasing prevalence of cardiovascular diseases in the region has driven the demand for effective treatment options such as drug eluting stents

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of Cardiovascular Diseases
    • 3.4.2. Technological Advancements in Stent Design
    • 3.4.3. Growing Geriatric Population
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Drug Eluting Stents
  • 3.6. Penetration And Growth Prospect Mapping 2022
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.7.2. Porter's Five Forces Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Drug Eluting Stent Market: Coating Type Segment Analysis

  • 4.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 4.2. Polymer-Based Coating
    • 4.2.1. Polymer-Based Coating Market, 2018 - 2030 (USD Billion)
      • 4.2.1.1. Non-Biodegradable Polymers
      • 4.2.1.2. Biodegradable Polymers
  • 4.3. Polymer-free Coating
    • 4.3.1. Polymer-Free Coating Market, 2018 - 2030 (USD Billion)
      • 4.3.1.1. Micro Porous Surface
      • 4.3.1.2. Micro Structured Surface
      • 4.3.1.3. Slotted Tubular Surface
      • 4.3.1.4. Nanoporous Surface

Chapter 5. Drug Eluting Stent Market: Application Segment Analysis

  • 5.1. Drug Eluting Stent: Market Share Analysis, 2022 & 2030
  • 5.2. Coronary Artery Disease
    • 5.2.1. Coronary Artery Disease Market, 2018 - 2030 (USD Billion)
  • 5.3. Peripheral Artery Disease
    • 5.3.1. Peripheral Artery Disease Market, 2018 - 2030 (USD Billion)

Chapter 6. Drug Eluting Stent Market: Regional Analysis

  • 6.1. Drug Eluting Stent Market Share, By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Drug Eluting Stent Market, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Drug Eluting Stent Market, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Abbott Laboratories
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Terumo Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Biosensors International
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Cook Medical
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. B. Braun
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Biotronik
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Lepu Medical Technology
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Drug eluting stent market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2022
  • Fig. 15 Global drug eluting stent market: Coating type movement analysis
  • Fig. 16 Global drug eluting stent market, for polymer-based coating, 2018 - 2030 (USD Billion)
  • Fig. 17 Global drug eluting stent market, for polymer-free coating, 2018 - 2030 (USD Billion)
  • Fig. 18 Global drug eluting stent market: Application movement analysis
  • Fig. 19 Global drug eluting stent market, for coronary artery disease, 2018 - 2030 (USD Billion)
  • Fig. 20 Global drug eluting stent market, for peripheral artery disease, 2018 - 2030 (USD Billion)
  • Fig. 21 Regional marketplace: Key takeaways
  • Fig. 22 Regional outlook, 2022 & 2030
  • Fig. 23 Global drug eluting stent market: Regional movement analysis
  • Fig. 24 North America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 25 U.S. drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 26 Canada drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 27 Europe drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 28 Germany drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 29 UK drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 30 France drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 31 Italy drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 32 Spain drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 33 Denmark drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 34 Sweden drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 35 Norway drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 36 Asia Pacific drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 37 Japan drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 38 China drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 39 India drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 40 Australia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 41 South Korea drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 42 Thailand drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 43 Latin America drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 44 Brazil drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 45 Mexico drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 46 Argentina drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 47 Middle East and Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 48 South Africa drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 49 Saudi Arabia drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 50 UAE drug eluting stent market, 2018 - 2030 (USD Billion)
  • Fig. 51 Kuwait drug eluting stent market, 2018 - 2030 (USD Billion)